222 related articles for article (PubMed ID: 31512372)
1. MicroRNAs expression profiling in Egyptian colorectal cancer patients.
Bader El Din NG; Ibrahim MK; El-Shenawy R; Salum GM; Farouk S; Zayed N; Khairy A; El Awady M
IUBMB Life; 2020 Feb; 72(2):275-284. PubMed ID: 31512372
[TBL] [Abstract][Full Text] [Related]
2. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
3. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
[TBL] [Abstract][Full Text] [Related]
4. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
[TBL] [Abstract][Full Text] [Related]
5. Differential Expression of miR-21, miR-23a, and miR-27a, and Their Diagnostic Significance in Egyptian Colorectal Cancer Patients.
Farouk S; Khairy A; Salem AM; Soliman AF; Bader El Din NG
Genet Test Mol Biomarkers; 2020 Dec; 24(12):825-834. PubMed ID: 33290159
[No Abstract] [Full Text] [Related]
6. The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer.
Xu L; Li M; Wang M; Yan D; Feng G; An G
BMC Cancer; 2014 Sep; 14():714. PubMed ID: 25255814
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of miRNA 26a and 26b with MMP-9 are valuable diagnostic biomarkers for colorectal cancer patients.
Farouk S; El-Shenawy R; Khairy AM; Bader El-Din NG
Biomark Med; 2023 Feb; 17(3):159-169. PubMed ID: 37097025
[TBL] [Abstract][Full Text] [Related]
9. MiRNAs as molecular biomarkers in stage II egyptian colorectal cancer patients.
Bahnassy AA; Salem SE; El-Sayed M; Khorshid O; Abdellateif MS; Youssef AS; Mohanad M; Hussein M; Zekri AN; Ali NM
Exp Mol Pathol; 2018 Dec; 105(3):260-271. PubMed ID: 30213464
[TBL] [Abstract][Full Text] [Related]
10. Circulating exosomal microRNAs as biomarkers of colon cancer.
Ogata-Kawata H; Izumiya M; Kurioka D; Honma Y; Yamada Y; Furuta K; Gunji T; Ohta H; Okamoto H; Sonoda H; Watanabe M; Nakagama H; Yokota J; Kohno T; Tsuchiya N
PLoS One; 2014; 9(4):e92921. PubMed ID: 24705249
[TBL] [Abstract][Full Text] [Related]
11. A panel of microRNA signature in serum for colorectal cancer diagnosis.
Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P
Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881
[TBL] [Abstract][Full Text] [Related]
12. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
[TBL] [Abstract][Full Text] [Related]
13. Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.
Zekri AR; Youssef AS; Lotfy MM; Gabr R; Ahmed OS; Nassar A; Hussein N; Omran D; Medhat E; Eid S; Hussein MM; Ismail MY; Alenzi FQ; Bahnassy AA
PLoS One; 2016; 11(5):e0154130. PubMed ID: 27135244
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer.
Ghanbari R; Mosakhani N; Asadi J; Nouraee N; Mowla SJ; Poustchi H; Malekzadeh R; Knuutila S
Cancer Biomark; 2015; 15(2):189-95. PubMed ID: 25519020
[TBL] [Abstract][Full Text] [Related]
15. Expression Analysis of Previously Verified Fecal and Plasma Dow-regulated MicroRNAs (miR-4478, 1295-3p, 142-3p and 26a-5p), in FFPE Tissue Samples of CRC Patients.
Ghanbari R; Rezasoltani S; Hashemi J; Mohamadkhani A; Tahmasebifar A; Arefian E; Mobarra N; Asadi J; Nazemalhosseini Mojarad E; Yazdani Y; Knuutila S; Malekzadeh R
Arch Iran Med; 2017 Feb; 20(2):92-95. PubMed ID: 28193082
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of potential biomarkers for the detection of dysregulated microRNA by qPCR in patients with colorectal adenocarcinoma.
Wu X; Xu X; Li S; Wu S; Chen R; Jiang Q; Liu H; Sun Y; Li Y; Xu Y
PLoS One; 2015; 10(3):e0120024. PubMed ID: 25803870
[TBL] [Abstract][Full Text] [Related]
17. Molecular expression profiles of selected microRNAs in colorectal adenocarcinoma in patients from south-eastern part of Romania.
Brînzan C; Aşchie M; Matei E; Mitroi A; Cozaru G
Medicine (Baltimore); 2019 Nov; 98(47):e18122. PubMed ID: 31764853
[TBL] [Abstract][Full Text] [Related]
18. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of the miRNAs, miR-194, and miR-29b, as clinically useful biomarkers for colorectal cancer.
Basati G; Razavi AE; Pakzad I; Malayeri FA
Tumour Biol; 2016 Feb; 37(2):1781-8. PubMed ID: 26318304
[TBL] [Abstract][Full Text] [Related]
20. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.
Luo X; Stock C; Burwinkel B; Brenner H
PLoS One; 2013; 8(5):e62880. PubMed ID: 23690963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
